The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Relmada Therapeutics Inc’s current trading price is -93.43% away from its 52-week high, while its distance from the 52-week low is 38.93%. The stock’s price
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Relmada Therapeutics Inc’s current trading price is -93.64% away from its 52-week high, while its distance from the 52-week low is 34.37%. The stock’s
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -91.49% since the start of this calendar year. Looking back
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Relmada Therapeutics Inc’s current trading price is -94.99% away from its 52-week high, while its distance from the 52-week low
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Relmada Therapeutics Inc’s current trading price is -94.22% away from its 52-week high, while its distance from the 52-week low is -3.36%. The stock’s price
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Relmada Therapeutics Inc’s current trading price is -90.72% away from its 52-week high, while its distance from the 52-week low is -64.36%. The stock’s
All rights reserved © 2024, Powered By Smart TechOne
